CBG Oil

CBG (cannabigerol) is a phytocannabinoid that is extracted from the hemp plant. While most people are now familiar with CBD or THC, CBG oil and its positive effects are still largely unknown, despite the fact that CBG is the "original cannabinoid" par excellence.

Whether you’re facing nausea, anxiety, stress or pain: CBG oil can highly improve your quality of life. Try out enecta's valuable CBG oils. At enecta we only offer CBG oil, which we produce ourselves from 100 percent natural raw materials!

1 products

concentration

G 500 - Premium CBG Oil

Organic and certified cannabigerol oil.

€22.95

Table of contents

What is CBG oil?

CBG oil is a hemp-derived product containing cannabigerol (CBG), a non-psychoactive cannabinoid found in cannabis plants. Unlike its more well-known counterpart CBD, CBG is often referred to as the "mother of all cannabinoids" due to its role as a precursor molecule in the formation of other cannabinoids [Russo].

The extraction of CBG typically occurs from young hemp plants, as CBG content decreases as the plant matures. Manufacturers utilize various extraction methods, including CO2 extraction and ethanol extraction, to isolate CBG from hemp biomass. The resulting extract is then combined with a carrier oil, such as MCT oil or hemp seed oil, to create CBG oil [Citti].

Chemical composition of CBG oil

CBG oil primarily consists of cannabigerol and a carrier oil. However, depending on the extraction method and product formulation, it may also contain other cannabinoids, terpenes, and flavonoids naturally present in hemp plants. Full-spectrum CBG oils retain these additional compounds, while isolate-based products contain only pure CBG [Nachnani].

Component	Description
Cannabigerol (CBG)	Primary active ingredient
Carrier oil	Facilitates absorption and dosing
Minor cannabinoids	Present in full-spectrum formulations
Terpenes	Aromatic compounds with potential benefits

CBG interacts with the endocannabinoid system, a complex network of receptors and signaling molecules throughout the body. This interaction may contribute to various potential health benefits, which have sparked interest in CBG oil as a natural wellness product [Navarro].

The effect of CBG oil

CBG oil interacts with the endocannabinoid system (ECS) in a unique manner, distinguishing it from other cannabinoids. Unlike THC, CBG does not produce psychoactive effects, instead functioning as a partial agonist at CB1 and CB2 receptors. This interaction may contribute to its potential therapeutic properties [Navarro].

Research suggests that CBG oil may influence neurotransmitter levels in the brain. It has been observed to inhibit the reuptake of neurotransmitters such as anandamide and GABA, potentially affecting mood, pain perception, and stress responses. Additionally, CBG demonstrates an ability to block serotonin receptors, which could impact various physiological processes [Cascio].

Cellular and molecular effects

At a cellular level, CBG exhibits antioxidant properties, potentially protecting cells from oxidative stress. Studies have shown that CBG may influence gene expression related to inflammation and cell growth, suggesting a role in modulating immune responses and cellular health [Borrelli].

Modulation of ion channels, affecting neuronal excitability
Potential neuroprotective effects through anti-inflammatory actions
Influence on appetite regulation via interaction with specific receptors

CBG's effects on the body are still being extensively researched, with ongoing studies exploring its potential in various therapeutic applications. While promising, it's crucial to note that many effects observed in laboratory settings require further clinical validation to fully understand their implications for human health [Deiana].

Uses of CBG oil

CBG oil has garnered attention for its potential therapeutic applications across various health conditions. Research suggests its efficacy in managing inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. In animal studies, CBG demonstrated an ability to reduce inflammation and oxidative stress in the intestinal tissue [Borrelli].

Neurological disorders represent another area where CBG oil shows promise. Preliminary studies indicate potential neuroprotective properties, which may be beneficial in conditions like Huntington's disease and Parkinson's disease. CBG's interaction with the endocannabinoid system appears to influence neurotransmitter function and neuroinflammation [Valdeolivas].

Emerging applications

Glaucoma management: CBG may help reduce intraocular pressure
Antibacterial properties: Effective against resistant bacterial strains
Appetite stimulation: Potential use in cachexia and eating disorders
Skin conditions: Topical application for psoriasis and eczema

In the realm of cancer research, CBG has shown potential in inhibiting the growth of colorectal cancer cells in preclinical studies. While these findings are promising, it's crucial to emphasize that more extensive clinical trials are necessary to fully understand CBG's efficacy and safety in human subjects [Borrelli].

As research progresses, the applications of CBG oil continue to expand. Some users report benefits for anxiety and stress management, though these effects require further scientific validation. Products like Enecta's CBG oil offer a means to explore these potential benefits, but should be used under professional guidance.

Benefits of CBG oil

CBG oil offers a range of potential benefits, stemming from its unique interaction with the endocannabinoid system. One of its most promising attributes lies in its anti-inflammatory properties. Studies have shown that CBG can inhibit the production of pro-inflammatory cytokines, potentially alleviating symptoms associated with chronic inflammatory conditions [Pellati].

Neuroprotection stands out as another significant benefit of CBG oil. Research indicates that CBG may help protect neurons from oxidative stress and inflammation, which could have implications for neurodegenerative disorders. This neuroprotective effect is attributed to CBG's ability to activate peroxisome proliferator-activated receptors (PPARs) [Granja].

Physiological and metabolic benefits

Appetite stimulation: CBG may help regulate metabolism and food intake
Bone formation: Potential to promote osteoblast function and bone growth
Bladder dysfunction: May reduce bladder contractions in overactive bladder syndrome
Antibacterial action: Effective against methicillin-resistant Staphylococcus aureus (MRSA)

CBG oil has demonstrated potential in supporting eye health. Its ability to reduce intraocular pressure could be beneficial for individuals with glaucoma. Additionally, CBG's antioxidant properties may protect against oxidative stress in the retina [Colasanti].

Emerging research suggests CBG oil may have anti-cancer properties. In preclinical studies, CBG has shown the ability to inhibit the growth of certain cancer cells and induce apoptosis. However, these findings require further investigation in clinical settings to establish their relevance in human cancer treatment [Borrelli].

How to take CBG oil

CBG oil can be administered through various methods, each offering distinct advantages in terms of absorption and onset of effects. Sublingual administration remains one of the most popular and efficient methods. By placing drops of CBG oil under the tongue and holding for 60-90 seconds before swallowing, the active compounds are absorbed directly into the bloodstream through the sublingual glands [Millar].

Oral ingestion presents another viable option for CBG oil consumption. This method involves swallowing the oil directly or mixing it with food or beverages. While this approach may result in a slower onset of effects due to first-pass metabolism in the liver, it potentially offers longer-lasting benefits [Bruni].

Alternative administration methods

Topical application: Directly on skin for localized effects
Vaporization: Inhaling CBG-rich e-liquids for rapid absorption
Suppositories: For targeted relief in specific areas
Transdermal patches: Slow, steady release over extended periods

The timing of CBG oil administration can significantly impact its effectiveness. For conditions requiring consistent cannabinoid levels, such as chronic pain or anxiety, regular dosing throughout the day may be beneficial. Conversely, for sleep-related issues, evening administration might be more appropriate [Russo].

When integrating CBG oil into a wellness routine, starting with a low dose and gradually increasing is advisable. This approach allows for careful monitoring of individual responses and minimizes the risk of potential side effects. High-quality products, like those offered by Enecta, often come with detailed dosing instructions to guide users in their CBG journey.

CBG oil dosage

Determining the optimal CBG oil dosage remains a complex task due to the variability in individual physiology, the condition being addressed, and the concentration of CBG in the product. Current research suggests that CBG may be effective at doses ranging from 25mg to 600mg per day, depending on the specific application [Nachnani].

Factors influencing CBG dosage include body weight, metabolism, and the severity of symptoms. A general guideline for beginners involves starting with a low dose of 5-10mg of CBG per day and gradually increasing by 5mg increments every week until the desired effects are achieved. This approach, known as titration, allows for the identification of the minimum effective dose while minimizing potential side effects [Russo].

Dosage considerations for specific conditions

Inflammatory bowel disease: 30-100mg daily, divided into multiple doses
Glaucoma: 20-40mg, administered in eye drops or sublingual oil
Neuroprotection: 50-200mg daily, based on preliminary studies
Antibacterial applications: Topical preparations with 1-5% CBG concentration

The bioavailability of CBG oil can significantly impact dosage requirements. Sublingual administration typically offers higher bioavailability compared to oral ingestion, potentially allowing for lower doses to achieve similar effects. Factors such as food intake and the presence of other medications can also influence CBG absorption and metabolism [Millar].

It's crucial to emphasize that these dosage suggestions are based on preliminary research and anecdotal evidence. Consultation with a healthcare professional familiar with cannabinoid therapy is strongly recommended before initiating a CBG regimen, especially for individuals with pre-existing medical conditions or those taking other medications.

Side effects of CBG oil

While CBG oil is generally well-tolerated, some users may experience adverse reactions. Gastrointestinal discomfort, including nausea and diarrhea, has been reported in a small percentage of individuals. These effects are often dose-dependent and may subside with continued use or dose adjustment [Nachnani].

Changes in appetite have been observed in some CBG users. Unlike THC, which typically stimulates appetite, CBG's effects on hunger can vary. Some individuals report increased appetite, while others experience a reduction in food intake. This variability underscores the importance of monitoring personal responses to CBG supplementation [Brierley].

Potential interactions and precautions

Drug interactions: CBG may affect the metabolism of certain medications
Blood pressure: Possible hypotensive effects in susceptible individuals
Dry mouth: Temporary reduction in saliva production
Drowsiness: Mild sedative effects reported in some users

CBG's impact on liver function warrants consideration. Preliminary studies suggest that high doses of cannabinoids may influence liver enzyme levels. Individuals with pre-existing liver conditions or those taking hepatotoxic medications should exercise caution and consult healthcare professionals before using CBG oil [Ewing].

Long-term effects of CBG use remain an area of ongoing research. While current data suggests a favorable safety profile, the lack of extensive clinical trials necessitates a cautious approach. Users are advised to start with low doses and closely monitor their body's response. Products from reputable manufacturers, such as Enecta, often provide detailed safety information and recommended usage guidelines to minimize potential risks.

What should I look for when buying CBG oil?

When selecting CBG oil, the source of hemp plays a crucial role in product quality. Organic, non-GMO hemp cultivated in regions with strict agricultural regulations typically yields higher-quality cannabinoids. Soil conditions, climate, and farming practices significantly influence the plant's cannabinoid profile and potential contaminant levels [Citti].

Extraction methods directly impact the purity and potency of CBG oil. CO2 extraction is widely regarded as the gold standard, producing clean, high-quality extracts without residual solvents. Ethanol extraction, while effective, may require additional purification steps to ensure product safety [Brighenti].

Key factors in CBG oil selection

Third-party lab testing: Verifies cannabinoid content and checks for contaminants
Full-spectrum vs. isolate: Determines the presence of additional beneficial compounds
Carrier oil quality: Influences bioavailability and shelf life
Concentration: Affects dosing precision and value for money

Transparency in labeling and marketing claims is paramount when evaluating CBG products. Reputable manufacturers provide detailed information about cannabinoid concentrations, sourcing practices, and potential allergens. Claims regarding specific health benefits should be approached with caution, as regulatory bodies strictly control such statements [Pavlovic].

The reputation and manufacturing standards of the producer merit careful consideration. Companies adhering to Good Manufacturing Practices (GMP) and providing comprehensive customer support often deliver superior products. Some brands, like Enecta, offer educational resources and personalized guidance to help consumers make informed decisions about CBG oil usage.

What does our CBG oil contain?

High-quality CBG oil comprises a carefully balanced blend of cannabigerol and select carrier oils. The primary active ingredient, cannabigerol, is typically present in concentrations ranging from 2.5% to 10%, with some premium products offering even higher potencies. These concentrations are achieved through precise extraction and formulation processes [Citti].

Carrier oils play a crucial role in CBG oil formulations, enhancing bioavailability and shelf life. Common choices include medium-chain triglyceride (MCT) oil, hemp seed oil, and olive oil. Each carrier offers unique benefits; for instance, MCT oil facilitates rapid absorption, while hemp seed oil provides additional nutritional value through its omega fatty acid content [Pavlovic].

Additional components in CBG oil

Terpenes: Aromatic compounds that may enhance therapeutic effects
Minor cannabinoids: CBN, CBC, and trace amounts of CBD or THC
Flavonoids: Plant compounds with antioxidant properties
Vitamins and minerals: Naturally occurring in hemp extracts

Full-spectrum CBG oils contain a diverse array of hemp-derived compounds, potentially offering enhanced benefits through the entourage effect. This synergistic interaction between cannabinoids, terpenes, and other phytonutrients may amplify the therapeutic potential of CBG [Russo].

Preservatives and additives are generally minimized in premium CBG oils to maintain product purity. Some formulations may include natural flavorings or essential oils to improve taste and aroma. Reputable manufacturers, such as Enecta, prioritize transparency by providing detailed certificates of analysis, allowing consumers to verify the exact composition of their CBG oil products.

How to determine CBG oil quality

Assessing CBG oil quality involves a multifaceted approach, beginning with an examination of the hemp source. Premium CBG oils are derived from organically grown, non-GMO hemp cultivated in regions with stringent agricultural regulations. Soil quality and farming practices significantly influence the cannabinoid profile and purity of the final product [Citti].

Extraction methods play a pivotal role in determining CBG oil quality. Supercritical CO2 extraction is widely regarded as the gold standard, producing clean, solvent-free extracts. This method preserves the delicate terpene profile while effectively isolating cannabinoids, resulting in a high-quality, full-spectrum product [Brighenti].

Key indicators of CBG oil quality

Cannabinoid profile: Consistent CBG concentration with minimal THC
Terpene retention: Presence of beneficial aromatic compounds
Absence of contaminants: No pesticides, heavy metals, or microbial growth
Clarity and color: Light to amber hue, free from particulates

Third-party laboratory testing serves as a crucial quality assurance measure. Comprehensive lab reports should detail cannabinoid and terpene profiles, while also screening for potential contaminants. Reputable manufacturers readily provide these certificates of analysis, ensuring transparency and product safety [Pavlovic].

The stability and shelf life of CBG oil are indicative of its quality. Premium products maintain potency over time when stored properly, typically in dark glass bottles to protect against light degradation. Some manufacturers, like Enecta, employ advanced packaging technologies to preserve product integrity and extend shelf life, further ensuring consistent quality throughout the product's lifespan.

How is CBG oil made?

The production of CBG oil begins with the careful selection of hemp strains rich in cannabigerol. These specialized cultivars are harvested early in the flowering cycle when CBG levels peak, typically around 6-8 weeks into the growing season. Timing is crucial, as CBG content diminishes as the plant matures, converting into other cannabinoids [Fellermeier].

Following harvest, the plant material undergoes a drying and curing process to preserve cannabinoid integrity. The dried biomass is then finely ground to increase surface area, optimizing extraction efficiency. This preparation phase is critical for maximizing CBG yield in subsequent steps [Brighenti].

Extraction and refinement process

Supercritical CO2 extraction: Pressurized carbon dioxide isolates cannabinoids
Winterization: Removes waxes and lipids from the raw extract
Decarboxylation: Converts CBGa to active CBG through controlled heating
Distillation: Further purifies and concentrates the CBG extract

The refined CBG extract is then combined with a carrier oil, typically MCT or hemp seed oil, to create the final CBG oil product. This formulation process requires precise measurements to achieve consistent cannabinoid concentrations. Some manufacturers employ proprietary blending techniques to enhance bioavailability and stability [Citti].

Quality control measures are implemented throughout the production process, including in-process testing and final product analysis. Advanced chromatography techniques, such as HPLC, are utilized to verify cannabinoid profiles and detect potential contaminants. Leading producers, including Enecta, often exceed regulatory requirements, employing rigorous testing protocols to ensure product safety and efficacy.

CBG Oil Testimonials

User experiences with CBG oil vary widely, reflecting the compound's diverse potential effects. A survey of 127 CBG users revealed that 51% reported improved mood, while 44% noted a reduction in chronic pain symptoms. These findings, while preliminary, suggest promising applications for CBG in mental health and pain management [Nachnani].

Anecdotal reports from individuals with inflammatory bowel conditions have highlighted CBG's potential gastrointestinal benefits. Several users described significant reductions in abdominal discomfort and improved regularity after incorporating CBG oil into their wellness routines. However, these observations require validation through controlled clinical studies [Borrelli].

Reported benefits from CBG oil users

Enhanced focus and mental clarity during work hours
Reduced anxiety symptoms in social situations
Improved sleep quality and duration
Alleviation of muscle soreness post-exercise

In the realm of skincare, CBG oil has garnered attention for its potential anti-inflammatory properties. Users with acne-prone skin have reported reductions in redness and breakouts following topical application. These accounts align with preliminary research suggesting CBG's ability to modulate sebum production [Oláh].

While individual experiences are valuable, it's crucial to approach testimonials with a critical mindset. Factors such as dosage, product quality, and individual physiology can significantly influence outcomes. Reputable manufacturers like Enecta often provide platforms for users to share their experiences, fostering a community of informed consumers while emphasizing the importance of personalized approaches to CBG use.

Legal status of CBG Oil

The legal landscape surrounding CBG oil varies significantly across jurisdictions, reflecting the complex regulatory environment of cannabis-derived products. In the United States, CBG oil derived from hemp containing less than 0.3% THC is federally legal under the 2018 Farm Bill. However, individual states may impose additional restrictions or requirements [Mead].

Within the European Union, CBG oil's legal status is subject to interpretation of the Novel Food Regulation. While some member states consider CBG a novel food requiring pre-market authorization, others adopt a more lenient approach. This regulatory ambiguity has led to varying levels of CBG oil availability across EU countries [EFSA].

Global legal considerations for CBG oil

Canada: Legal if derived from industrial hemp and containing minimal THC
UK: Permitted as a food supplement, subject to novel food regulations
Australia: Classified as a prescription-only substance
Japan: Legal for distribution, with strict THC content limits

Import and export regulations for CBG oil can be particularly complex, with requirements varying based on origin, destination, and product composition. Manufacturers must navigate a patchwork of international laws to ensure compliance throughout their supply chains [Riboulet-Zemouli].

As research into CBG's potential therapeutic applications progresses, regulatory frameworks are likely to evolve. Consumers are advised to stay informed about local laws and purchase from reputable sources. Companies like Enecta prioritize regulatory compliance, offering products that meet legal standards across multiple markets while advocating for clear, science-based regulations to ensure consumer access to safe, high-quality CBG oil.

Bibliography

Borrelli, F., et al. "Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid." Carcinogenesis, vol. 35, no. 12, 2014, pp. 2787-2797.

Brighenti, V., et al. "Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp)." Journal of Pharmaceutical and Biomedical Analysis, vol. 143, 2017, pp. 228-236.

Brierley, D.I., et al. "Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats." Psychopharmacology, vol. 233, no. 19-20, 2016, pp. 3603-3613.

Cascio, M.G., et al. "Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist." British Journal of Pharmacology, vol. 159, no. 1, 2010, pp. 129-141.

Citti, C., et al. "Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA)." Journal of Pharmaceutical and Biomedical Analysis, vol. 149, 2018, pp. 532-540.

Colasanti, B.K. "A comparison of the ocular and central effects of Δ9-tetrahydrocannabinol and cannabigerol." Journal of Ocular Pharmacology and Therapeutics, vol. 6, no. 4, 1990, pp. 259-269.

Deiana, S. "Potential Medical Uses of Cannabigerol: A Brief Overview." Handbook of Cannabis and Related Pathologies, 2017, pp. 958-967.

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). "Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed." EFSA Journal, vol. 9, no. 3, 2011, p. 2011.

Ewing, L.E., et al. "Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model." Molecules, vol. 24, no. 9, 2019, p. 1694.

Fellermeier, M., et al. "Biosynthesis of cannabinoids: Incorporation experiments with 13C-labeled glucoses." European Journal of Biochemistry, vol. 268, no. 6, 2001, pp. 1596-1604.

Granja, A.G., et al. "A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis." Journal of Neuroimmune Pharmacology, vol. 7, no. 4, 2012, pp. 1002-1016.

Mead, A. "Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States." Frontiers in Plant Science, vol. 10, 2019, p. 697.

Millar, S.A., et al. "A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans." Frontiers in Pharmacology, vol. 9, 2018, p. 1365.

Nachnani, R., et al. "The Pharmacological Case for Cannabigerol." Journal of Pharmacology and Experimental Therapeutics, vol. 376, no. 2, 2021, pp. 204-212.

Navarro, G., et al. "Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes." Frontiers in Pharmacology, vol. 9, 2018, p. 632.

Oláh, A., et al. "Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes." Journal of Clinical Investigation, vol. 124, no. 9, 2014, pp. 3713-3724.

Pavlovic, R., et al. "Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations." Molecules, vol. 23, no. 5, 2018, p. 1230.

Pellati, F., et al. "New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp)." Molecules, vol. 23, no. 10, 2018, p. 2639.

Riboulet-Zemouli, K., et al. "Cannabis and the Convention on Psychotropic Substances." Drug Science, Policy and Law, vol. 5, 2019, pp. 1-15.

Russo, E.B. "The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No "Strain," No Gain." Frontiers in Plant Science, vol. 9, 2019, p. 1969.

Valdeolivas, S., et al. "Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice." Neurotherapeutics, vol. 12, no. 1, 2015, pp. 185-199.